Dermoval
PreclinicalSmall molecule
Dermoval is one of 5 small molecule programs targeting Pemphigus. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
4 competitors in Pemphigus
#DrugCompanyPhaseTrials
1Rituxan
RocheApproved
Imuran
LLegacy Health System
Approved
B007
SShanghai Jiaolian Drug Research and Development Co., Ltd
Phase 3
Kesimpta
NovartisPreclinical
Dermoval
UUniversity Hospital, Rouen
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dermoval. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity Hospital, Rouen